Zhong Guo Zheng Quan Bao·2025-11-10 20:09Core Insights - A total of 9 listed companies in A-shares have disclosed their performance forecasts for the year 2025, with varying outcomes including losses, slight increases, slight decreases, and uncertainties [1] - Lixun Precision expects a net profit attributable to shareholders of approximately 16.518 billion to 17.186 billion yuan for 2025, representing a year-on-year growth of 23.59% to 28.59% [1] - BeiGene has adjusted its revenue forecast for 2025 to approximately 36.2 billion to 38.1 billion yuan, citing its leading position in the U.S. market as a key factor for growth [2] - Chipone Integrated Circuit anticipates a revenue of 8 billion to 8.3 billion yuan for 2025, with a year-on-year growth of 23% to 28% [4] Company Performance - Lixun Precision aims to enhance its global strategy and manufacturing solutions, focusing on AI technology integration and diversified business expansion [1] - BeiGene's revenue adjustment is attributed to its expansion in key global markets and improved operational efficiency [2] - Chipone Integrated Circuit is benefiting from the growth in the new energy sector and increasing domestic semiconductor demand [4] - Evert and Chipone Integrated Circuit are among the companies expecting continued losses in 2025 [3] Institutional Research Focus - Institutional investors are increasingly interested in the new product launches, R&D investments, and future development plans of listed companies [5] - BeiGene is conducting clinical trials for its product in nephropathy and is optimistic about its prospects [6] - Lixun Precision is increasing its R&D investments in core technologies and optimizing its production layout to adapt to market changes [6]